Similar articles

• Parkinson disease: How reliable are prodromal indicators of Parkinson disease?

  Silveira-Moriyama L, Lees AJ. Silveira-Moriyama L, et al. Nat Rev Neurol. 2015 Jan;11(1):5-6. doi: 10.1038/nrneurol.2014.235. Epub 2014 Dec 16. Nat Rev Neurol. 2015. PMID: 25511898 No abstract available.
• FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.

  Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH. Meles SK, et al. Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22. Mov Disord. 2017. PMID: 28734065 Free PMC article.
• The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.

  Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, Duda JE, Facheris M, Fernández-Santiago R, Marek K, Lomeña F, Marras C, Mondragon E, Saunders-Pullman R, Waro B; LRRK2 Cohort Consortium. Pont-Sunyer C, et al. Mov Disord. 2017 May;32(5):726-738. doi: 10.1002/mds.26964. Epub 2017 Mar 28. Mov Disord. 2017. PMID: 28370517
• Advances in markers of prodromal Parkinson disease.

  Postuma RB, Berg D. Postuma RB, et al. Nat Rev Neurol. 2016 Oct 27;12(11):622-634. doi: 10.1038/nrneurol.2016.152. Nat Rev Neurol. 2016. PMID: 27786242 Review.
• Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.

  Postuma RB, Berg D. Postuma RB, et al. Mov Disord. 2019 May;34(5):665-675. doi: 10.1002/mds.27670. Epub 2019 Mar 28. Mov Disord. 2019. PMID: 30919499 Review.